Skip to main content
Premium Trial:

Request an Annual Quote

Genetron Health, Yikon Genomics Team up for Reproductive Health Sequencing Assays

NEW YORK – Genetron Health said on Monday that it has entered into a strategic partnership with reproductive health firm Yikon Genomics.

Financial and other terms of the deal between the two Chinese firms were not disclosed, but Genetron said it expects the partnership to contribute to its 2021 revenues.

Under the agreement, Shanghai-based Yikon will have exclusive rights to use Genetron's benchtop S5 sequencing instrument for reproductive health applications in China. In addition, the companies will work together to develop and register new tests for the platform, Genetron said in a statement.

Beijing-based Genetron will also support Yikon's commercialization efforts. Yikon currently provides pre-pregnancy, prenatal, and genetic disease testing for more than 400 hospital partners across China.

The S5 next-generation sequencing platform, which was approved by China's National Medical Products Administration in 2019, is based on Thermo Fisher Scientific's Ion GeneStudio S5 sequencer and has previously been used in various oncology settings.

In July, the company received CE marking for its eight-gene lung cancer sequencing test running on the S5 platform.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.